HK Stock MarketDetailed Quotes

00460 SIHUAN PHARM

Watchlist

0.680
-0.030-4.23%

Market Closed Dec 13 16:08 CST

6.33BMarket Cap-170.00P/E (TTM)

SIHUAN PHARM Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

(FY)Dec 31, 2020

(Q6)Jun 30, 2020

(FY)Dec 31, 2019

Turnover

-10.04%949.7M

-14.70%1.86B

-27.90%1.06B

-28.21%2.18B

-23.23%1.46B

23.30%3.04B

80.86%1.91B

-14.39%2.46B

-36.56%1.05B

-1.34%2.88B

Operating income

-10.04%949.7M

-14.70%1.86B

-27.90%1.06B

-28.21%2.18B

-23.23%1.46B

23.30%3.04B

80.86%1.91B

-14.39%2.46B

-36.56%1.05B

-1.34%2.88B

Cost of sales

-10.78%-341.18M

18.56%-564.9M

33.12%-307.97M

-14.10%-693.61M

-4.64%-460.51M

-10.57%-607.9M

-63.92%-440.1M

6.66%-549.78M

8.76%-268.48M

-9.41%-588.99M

Operating expenses

-10.78%-341.18M

18.56%-564.9M

33.12%-307.97M

-14.10%-693.61M

-4.64%-460.51M

-10.57%-607.9M

-63.92%-440.1M

6.66%-549.78M

8.76%-268.48M

-9.41%-588.99M

Gross profit

-18.62%608.52M

-12.90%1.3B

-25.50%747.73M

-38.79%1.49B

-31.59%1B

26.95%2.43B

86.64%1.47B

-16.38%1.91B

-42.54%786.06M

-3.77%2.29B

Selling expenses

-0.46%-213.47M

6.13%-442.26M

7.47%-212.49M

12.22%-471.14M

11.99%-229.64M

-45.54%-536.74M

-91.13%-260.92M

-50.29%-368.79M

-13.51%-136.52M

9.49%-245.38M

Administrative expenses

-13.28%-240.34M

15.07%-468.96M

33.76%-212.17M

6.76%-552.19M

-14.95%-320.31M

-20.91%-592.22M

-31.35%-278.66M

-3.86%-489.78M

6.88%-212.16M

-19.05%-471.57M

Research and development expenses

33.48%-195.59M

38.32%-577.66M

35.70%-294.04M

-7.89%-936.58M

-37.08%-457.27M

-19.05%-868.07M

-10.87%-333.57M

-21.74%-729.16M

-20.51%-300.85M

-24.70%-598.95M

Impairment and provision

----

-1,215.43%-1.73B

---98.1M

---131.3M

----

---3.97B

-Impairment of property, machinery and equipment

----

---98.1M

----

-Goodwill impairment

----

---3.97B

-Other impairment is provision

----

-1,215.43%-1.73B

----

---131.3M

----

Special items of operating profit

28.06%149.98M

-3.74%354.93M

-61.58%117.12M

-21.51%368.73M

4.39%304.8M

2.04%469.78M

63.49%291.99M

-22.21%460.41M

-49.88%178.6M

-25.50%591.85M

Operating profit

-25.35%109.1M

108.83%161.7M

-28.06%146.16M

-337.16%-1.83B

-77.07%203.18M

-1.93%771.95M

181.14%885.96M

132.71%787.13M

118.35%315.14M

-218.77%-2.41B

Financing cost

0.81%-132.46M

-27.54%-269.34M

-34.35%-133.54M

-79.95%-211.18M

-529.99%-99.4M

-1,328.15%-117.35M

-894.83%-15.78M

-74.31%-8.22M

37.01%-1.59M

22.21%-4.71M

Special items of earning before tax

109.07%4.14M

33.70%-53.62M

4.32%-45.67M

49.00%-80.88M

5.85%-47.73M

-1,113.88%-158.58M

-343.60%-50.7M

-8.72%-13.06M

-61.13%-11.43M

-55.69%-12.02M

Earning before tax

41.88%-19.21M

92.40%-161.26M

-158.98%-33.05M

-527.97%-2.12B

-93.16%56.04M

-35.23%496.01M

171.24%819.48M

131.61%765.84M

117.50%302.12M

-220.42%-2.42B

Tax

43.24%-48.75M

51.00%-96.43M

43.47%-85.89M

22.25%-196.79M

32.55%-151.94M

-15.56%-253.12M

-68.83%-225.27M

24.57%-219.04M

43.75%-133.43M

12.75%-290.39M

After-tax profit from continuing operations

42.86%-67.96M

88.89%-257.69M

-24.02%-118.94M

-1,054.97%-2.32B

-116.14%-95.9M

-55.58%242.89M

252.25%594.22M

120.15%546.8M

108.59%168.69M

-261.57%-2.71B

After-tax profit from non-continuing business

----

458.51%36.3M

----

71.01%-10.12M

----

20.59%-34.92M

---24.44M

---43.97M

Earning after tax

42.86%-67.96M

88.71%-257.69M

-24.02%-118.94M

-1,080.92%-2.28B

-116.14%-95.9M

-54.53%232.77M

311.92%594.22M

118.56%511.89M

107.34%144.26M

-264.19%-2.76B

Minority profit

50.16%-34.53M

44.71%-203.67M

49.15%-69.3M

-100.48%-368.36M

-692.03%-136.28M

-577.18%-183.74M

-200.12%-17.21M

1,067.71%38.51M

-110.26%-5.73M

-106.70%-3.98M

Profit attributable to shareholders

32.67%-33.42M

97.18%-54.02M

-222.95%-49.64M

-559.75%-1.91B

-93.40%40.38M

-12.01%416.51M

307.64%611.42M

117.19%473.38M

107.43%149.99M

-269.96%-2.75B

Basic earnings per share

32.08%-0.0036

97.17%-0.0058

-223.26%-0.0053

-564.25%-0.2052

-93.34%0.0043

-11.60%0.0442

308.86%0.0646

117.18%0.05

107.41%0.0158

-270.18%-0.291

Diluted earnings per share

32.08%-0.0036

97.17%-0.0058

-223.26%-0.0053

-567.43%-0.2052

-93.30%0.0043

-12.20%0.0439

306.33%0.0642

117.18%0.05

107.41%0.0158

-270.18%-0.291

Currency Unit

CNY

Accounting Standards

IAS

Audit Opinions

Unqualified Opinion

Auditor

Ernst & Young

	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021	(FY)Dec 31, 2020	(Q6)Jun 30, 2020	(FY)Dec 31, 2019
Turnover	-10.04%949.7M	-14.70%1.86B	-27.90%1.06B	-28.21%2.18B	-23.23%1.46B	23.30%3.04B	80.86%1.91B	-14.39%2.46B	-36.56%1.05B	-1.34%2.88B
Operating income	-10.04%949.7M	-14.70%1.86B	-27.90%1.06B	-28.21%2.18B	-23.23%1.46B	23.30%3.04B	80.86%1.91B	-14.39%2.46B	-36.56%1.05B	-1.34%2.88B
Cost of sales	-10.78%-341.18M	18.56%-564.9M	33.12%-307.97M	-14.10%-693.61M	-4.64%-460.51M	-10.57%-607.9M	-63.92%-440.1M	6.66%-549.78M	8.76%-268.48M	-9.41%-588.99M
Operating expenses	-10.78%-341.18M	18.56%-564.9M	33.12%-307.97M	-14.10%-693.61M	-4.64%-460.51M	-10.57%-607.9M	-63.92%-440.1M	6.66%-549.78M	8.76%-268.48M	-9.41%-588.99M
Gross profit	-18.62%608.52M	-12.90%1.3B	-25.50%747.73M	-38.79%1.49B	-31.59%1B	26.95%2.43B	86.64%1.47B	-16.38%1.91B	-42.54%786.06M	-3.77%2.29B
Selling expenses	-0.46%-213.47M	6.13%-442.26M	7.47%-212.49M	12.22%-471.14M	11.99%-229.64M	-45.54%-536.74M	-91.13%-260.92M	-50.29%-368.79M	-13.51%-136.52M	9.49%-245.38M
Administrative expenses	-13.28%-240.34M	15.07%-468.96M	33.76%-212.17M	6.76%-552.19M	-14.95%-320.31M	-20.91%-592.22M	-31.35%-278.66M	-3.86%-489.78M	6.88%-212.16M	-19.05%-471.57M
Research and development expenses	33.48%-195.59M	38.32%-577.66M	35.70%-294.04M	-7.89%-936.58M	-37.08%-457.27M	-19.05%-868.07M	-10.87%-333.57M	-21.74%-729.16M	-20.51%-300.85M	-24.70%-598.95M
Impairment and provision	----	----	----	-1,215.43%-1.73B	---98.1M	---131.3M	----	----	----	---3.97B
-Impairment of property, machinery and equipment	----	----	----	----	---98.1M	----	----	----	----	----
-Goodwill impairment	----	----	----	----	----	----	----	----	----	---3.97B
-Other impairment is provision	----	----	----	-1,215.43%-1.73B	----	---131.3M	----	----	----	----
Special items of operating profit	28.06%149.98M	-3.74%354.93M	-61.58%117.12M	-21.51%368.73M	4.39%304.8M	2.04%469.78M	63.49%291.99M	-22.21%460.41M	-49.88%178.6M	-25.50%591.85M
Operating profit	-25.35%109.1M	108.83%161.7M	-28.06%146.16M	-337.16%-1.83B	-77.07%203.18M	-1.93%771.95M	181.14%885.96M	132.71%787.13M	118.35%315.14M	-218.77%-2.41B
Financing cost	0.81%-132.46M	-27.54%-269.34M	-34.35%-133.54M	-79.95%-211.18M	-529.99%-99.4M	-1,328.15%-117.35M	-894.83%-15.78M	-74.31%-8.22M	37.01%-1.59M	22.21%-4.71M
Special items of earning before tax	109.07%4.14M	33.70%-53.62M	4.32%-45.67M	49.00%-80.88M	5.85%-47.73M	-1,113.88%-158.58M	-343.60%-50.7M	-8.72%-13.06M	-61.13%-11.43M	-55.69%-12.02M
Earning before tax	41.88%-19.21M	92.40%-161.26M	-158.98%-33.05M	-527.97%-2.12B	-93.16%56.04M	-35.23%496.01M	171.24%819.48M	131.61%765.84M	117.50%302.12M	-220.42%-2.42B
Tax	43.24%-48.75M	51.00%-96.43M	43.47%-85.89M	22.25%-196.79M	32.55%-151.94M	-15.56%-253.12M	-68.83%-225.27M	24.57%-219.04M	43.75%-133.43M	12.75%-290.39M
After-tax profit from continuing operations	42.86%-67.96M	88.89%-257.69M	-24.02%-118.94M	-1,054.97%-2.32B	-116.14%-95.9M	-55.58%242.89M	252.25%594.22M	120.15%546.8M	108.59%168.69M	-261.57%-2.71B
After-tax profit from non-continuing business	----	----	----	458.51%36.3M	----	71.01%-10.12M	----	20.59%-34.92M	---24.44M	---43.97M
Earning after tax	42.86%-67.96M	88.71%-257.69M	-24.02%-118.94M	-1,080.92%-2.28B	-116.14%-95.9M	-54.53%232.77M	311.92%594.22M	118.56%511.89M	107.34%144.26M	-264.19%-2.76B
Minority profit	50.16%-34.53M	44.71%-203.67M	49.15%-69.3M	-100.48%-368.36M	-692.03%-136.28M	-577.18%-183.74M	-200.12%-17.21M	1,067.71%38.51M	-110.26%-5.73M	-106.70%-3.98M
Profit attributable to shareholders	32.67%-33.42M	97.18%-54.02M	-222.95%-49.64M	-559.75%-1.91B	-93.40%40.38M	-12.01%416.51M	307.64%611.42M	117.19%473.38M	107.43%149.99M	-269.96%-2.75B
Basic earnings per share	32.08%-0.0036	97.17%-0.0058	-223.26%-0.0053	-564.25%-0.2052	-93.34%0.0043	-11.60%0.0442	308.86%0.0646	117.18%0.05	107.41%0.0158	-270.18%-0.291
Diluted earnings per share	32.08%-0.0036	97.17%-0.0058	-223.26%-0.0053	-567.43%-0.2052	-93.30%0.0043	-12.20%0.0439	306.33%0.0642	117.18%0.05	107.41%0.0158	-270.18%-0.291
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS
Audit Opinions	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion
Auditor	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending HK Stocks